Extended data
The latest version of the catalogue is mainly based on the 20 12 version of the catalogue. Generally speaking, the 20 19 version of the Catalogue has the following characteristics:
1, the variety increased from 520 to 685, including 4 western medicines17 and 268 Chinese patent medicines (including ethnic medicines), which can better serve all kinds of medical and health institutions at all levels and promote the comprehensive allocation and priority use of essential medicines.
2. The structure has been optimized, highlighting the basic drug demand of common diseases, chronic diseases, diseases with heavy burden and great harm and public health, and paying attention to the drug use of special groups such as children. The new varieties include 12 tumor drugs and 22 kinds of drugs urgently needed in clinic for children.
3. Further standardizing dosage forms and specifications will be of great significance for guiding the production and circulation of essential drugs, bidding and purchasing, rational drug use, payment and reimbursement, and whole-process supervision.
4. Continue to pay equal attention to Chinese and Western medicine, increase the scope of functional indications, and cover more clinical symptoms of Chinese medicine.
5. The clinical necessity has been strengthened. Among the new drug varieties added in this catalogue adjustment, such as the direct antiviral drug Sophobouvir Patavir, experts agree that hepatitis C can be cured with definite curative effect.